{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:28:12Z","timestamp":1759692492107,"version":"3.41.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004418","name":"Vrije Universiteit Brussel","doi-asserted-by":"crossref","award":["OZR 2102"],"award-info":[{"award-number":["OZR 2102"]}],"id":[{"id":"10.13039\/501100004418","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FWO","award":["G.0163.10N"],"award-info":[{"award-number":["G.0163.10N"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neuropharm.2015.04.030","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T07:25:33Z","timestamp":1431156333000},"page":"415-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Neuropeptide FF receptors as novel targets for limbic seizure attenuation"],"prefix":"10.1016","volume":"95","author":[{"given":"Jeanelle","family":"Portelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Meurs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Bihel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joery","family":"De Kock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Utard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ine","family":"Buffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Coppens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Tourwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"De Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Vanhaecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Massie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambikaipakan","family":"Balasubramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Boon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Bourguignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Simonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Smolders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.04.030_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/jm010031k","article-title":"Highly selective and potent neuropeptide Y (NPY) Y1 receptor antagonists based on [Pro(30), Tyr(32), Leu(34)]NPY(28-36)-NH2 (BW1911U90)","volume":"44","author":"Balasubramaniam","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1460-9568.2003.02810.x","article-title":"Induced down-regulation of neuropeptide Y-Y1 receptors delays initiation of kindling","volume":"18","author":"Benmaamar","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.peptides.2009.11.009","article-title":"Central locomotor and cognitive effects of a NPFF receptor agonist in mouse","volume":"31","author":"Betourne","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(99)00381-X","article-title":"Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in\u00a0vitro via different NPY receptor subtypes","volume":"268","author":"Bijak","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib6","doi-asserted-by":"crossref","first-page":"39324","DOI":"10.1074\/jbc.M004385200","article-title":"Identification and characterization of two G protein-coupled receptors for neuropeptide FF","volume":"275","author":"Bonini","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(87)90391-X","article-title":"Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurones in\u00a0vitro","volume":"408","author":"Brooks","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ygcen.2008.09.001","article-title":"Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands","volume":"159","author":"Cline","year":"2008","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/laban0707-25","article-title":"Cecum location in rats and the implications for intraperitoneal injections","volume":"36","author":"Coria-Avila","year":"2007","journal-title":"Lab. Anim. (NY)"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuropharm.2013.07.012","article-title":"Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors","volume":"75","author":"Elhabazi","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/cmdc.201100089","article-title":"Structure-activity studies of RFamide peptides reveal subtype-selective activation of neuropeptide FF1 and FF2 receptors","volume":"6","author":"Findeisen","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1460-9568.1998.00061.x","article-title":"Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors","volume":"10","author":"Gariboldi","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib13","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1021\/jm9011998","article-title":"Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists","volume":"52","author":"Gaubert","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib14","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1016\/j.bmcl.2012.10.049","article-title":"Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors","volume":"22","author":"Gealageas","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/jo202018w","article-title":"Direct guanidinylation of aryl and heteroaryl halides via copper-catalyzed cross-coupling reaction","volume":"77","author":"Hammoud","year":"2012","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1474-4422(03)00482-4","article-title":"Neuropeptides: opportunities for drug discovery","volume":"2","author":"Hokfelt","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0143-4179(02)00086-0","article-title":"Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade","volume":"36","author":"Husum","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2826.2003.00869.x","article-title":"Central administration of neuropeptide FF causes activation of oxytocin paraventricular hypothalamic neurones that project to the brainstem","volume":"15","author":"Jhamandas","year":"2003","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib21","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(96)00838-2","article-title":"Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam","volume":"317","author":"Kask","year":"1996","journal-title":"Eur. J. Pharmacol."},{"year":"2003","series-title":"Preparation of Quinazolino- and Quinolinoguanidines as Ligands for Neuropeptide FF (NPFF) Receptors Patented by Synaptic Pharmaceuticals","author":"Kawakami","key":"10.1016\/j.neuropharm.2015.04.030_bib22"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/jpet.109.164384","article-title":"Neuropeptide FF receptors have opposing modulatory effects on nociception","volume":"334","author":"Lameh","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1528-1167.2006.00500.x","article-title":"Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice","volume":"47","author":"Lin","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/j.1528-1167.2006.00625.x","article-title":"Substantia nigra is an anticonvulsant site of action of topiramate in the focal pilocarpine model of limbic seizures","volume":"47","author":"Meurs","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib27","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2174\/156802607782340975","article-title":"Clinical potential of neuropeptide Y receptor ligands in the treatment of epilepsy","volume":"7","author":"Meurs","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib28","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/j.1460-9568.2007.05911.x","article-title":"Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y","volume":"26","author":"Meurs","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.04.030_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eplepsyres.2007.10.007","article-title":"Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin","volume":"78","author":"Meurs","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(02)02224-0","article-title":"Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists","volume":"451","author":"Mollereau","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1460-9568.2007.05348.x","article-title":"Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors","volume":"25","author":"Morris","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.npep.2010.05.003","article-title":"Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice","volume":"44","author":"Mouledous","year":"2010","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0026-895X(24)12616-8","article-title":"Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in\u00a0vivo","volume":"60","author":"Mullins","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0196-9781(95)02137-X","article-title":"Neuropeptide FF reduces food intake in rats","volume":"17","author":"Murase","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0301-0082(96)00001-9","article-title":"Neuropeptide FF, a mammalian neuropeptide with multiple functions","volume":"48","author":"Panula","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eplepsyres.2009.09.009","article-title":"Intrastrain differences in seizure susceptibility, pharmacological response and basal neurochemistry of Wistar rats","volume":"87","author":"Portelli","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s13311-012-0125-x","article-title":"Inactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents","volume":"9","author":"Portelli","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib38","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.peptides.2005.06.032","article-title":"Cardiovascular effects of neuropeptide FF antagonists","volume":"27","author":"Prokai","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2004.12.002","article-title":"Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists","volume":"508","author":"Quelven","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(99)02119-8","article-title":"Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition","volume":"848","author":"Redrobe","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0196-9781(01)00347-3","article-title":"Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation","volume":"22","author":"Reibel","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2005.08.060","article-title":"Anti-analgesia of a selective NPFF2 agonist depends on opioid activity","volume":"336","author":"Roussin","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0021-9258(19)40095-1","article-title":"Cloning and expression of a rat neuromedin K receptor cDNA","volume":"265","author":"Shigemoto","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib45","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1073\/pnas.0502090103","article-title":"RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia","volume":"103","author":"Simonin","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib46","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.bjp.0701231","article-title":"NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis","volume":"121","author":"Smolders","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(01)02267-4","article-title":"Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat","volume":"313","author":"Sunter","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0006-291X(05)81237-9","article-title":"FMRF-amide and L-Arg-L-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system","volume":"175","author":"Thiemermann","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0169-328X(95)00176-S","article-title":"Expression of the neuropeptide Y Y1 receptor in human embryonic kidney 293 cells: ligand binding characteristics, in situ hybridization and receptor autoradiography","volume":"34","author":"Tong","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"Suppl.\u00a06","key":"10.1016\/j.neuropharm.2015.04.030_bib50","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1111\/j.1528-1157.2000.tb01569.x","article-title":"Plastic changes in neuropeptide Y receptor subtypes in experimental models of limbic seizures","volume":"41","author":"Vezzani","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2015.04.030_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-3565(25)12029-6","article-title":"Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226","volume":"275","author":"Wieland","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nm0797-761","article-title":"Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors","volume":"3","author":"Woldbye","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.04.030_bib53","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.peptides.2010.03.036","article-title":"Distribution of neuropeptide FF (NPFF) receptors in correlation with morphine-induced reward in the rat brain","volume":"31","author":"Wu","year":"2010","journal-title":"Peptides"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815001598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T22:35:03Z","timestamp":1748385303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815001598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":50,"alternative-id":["S0028390815001598"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.04.030","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide FF receptors as novel targets for limbic seizure attenuation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}